Molloy Anthony's Form 4 filing
Pacira BioSciences, Inc. (PCRX) · filed Jan 6, 2023
- Accession no.
- 0001209191-23-002474
- Filed
- Jan 6, 2023
- Trade date
- Jan 4-5, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $27.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Molloy AnthonyCIK 0001900012 | Officer (Chief Lgl & Compliance Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | Common Stock | SSaleDisposed | −158 | $39.09 | −$6,176.22 | 19,996 | Direct | |
| Jan 5, 2023 | Common Stock | SSaleDisposed | −546 | $38.31 | −$20,917.26 | 19,450 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.